Skip to content

Effect of Inhibitory Kinesio-tape of the Upper Trapezius on Lower Trapezius Muscle Excitation

Effect of Inhibitory Kinesio-tape of the Upper Trapezius on Lower Trapezius Muscle Excitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04711447
Enrollment
25
Registered
2021-01-15
Start date
2020-01-01
Completion date
2020-07-01
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scapular Dyskinesis

Keywords

kinesio tape (KT), Shoulder, upper trapezius, lower trapezius

Brief summary

Shoulder pain increases excitation (or activity) of the upper trapezius (UT) and reduces excitation in lower trapezius (LT). Despite inconclusive evidence, kinesio-tape (KT) is often used to modify muscular excitation within the UT and/or LT to help correct alterations in scapular position and motion associated with shoulder pain/injury. The objectives of the current study were to determine if: 1) inhibitory KT to the UT acutely increases muscle excitation (whole-muscle and spatial distribution) within the LT in healthy individuals; and 2) if loading the limb alters the magnitude of change in muscle excitation of the LT. We hypothesize that: 1) inhibitory KT application to the UT will immediately increase whole-muscle LT excitation, and result in an inferior shift in the distribution of excitation within the LT compared to no tape and sham-KT tape conditions; and 2) the magnitude of immediate increase in LT excitation with KT would be greater in the loaded condition. A repeated-measures, crossover design was used to determine the impact of KT applied to UT and load on muscle excitation of the LT. Participants were asked to perform a repeated arm elevation task during three different taping conditions: no KT, experimental KT and sham KT. Each taping condition performed the repeated arm elevation task during two loading conditions: no load and loaded with 2.3 kilograms. All six conditions were tested during one visit with the no load condition preceding the loaded condition for each taping condition. A baseline trial (no KT; N-KT) was performed first, followed by both an experimental-KT (E-KT) and sham-KT (S-KT) condition. The order of the E-KT and S-KT conditions were randomized and the order was counterbalanced. Testing for each tape condition lasted approximately 10-minutes for a total of 45-minutes per participant including screening, EMG set-up and clean-up. KT was applied to the UT and muscle excitation (EMG amplitude) was measured in the LT using one single 32-grid high-density surface electromyography (HD-sEMG) electrode during a repeated arm elevation task.

Interventions

Twenty-two individuals with healthy shoulders completed 10 repetitions of an arm elevation task during three taping conditions (no-tape, experimental KT, sham KT) and 2 loading conditions (no-load and loaded).

Sponsors

Trisha Scribbans
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* right-handed individuals * no current shoulder pain or pathology in the shoulder, neck, back.

Exclusion criteria

* recent history (\<6 months) of injury or orthopedic disorder of the shoulder, upper back or neck (e.g. rotator cuff tears, disc pathologies, etc.) * neurological or musculoskeletal disorder (e.g. epilepsy, multiple sclerosis, etc.) * current pain in the shoulder, upper back or neck * previous allergies or skin irritation to adhesives.

Design outcomes

Primary

MeasureTime frameDescription
Whole-muscle ActivationMeasured during 2nd-9th repetitions of the arm elevation task. Each repetition lasted approximately 1.5 seconds, thus the timeframe was approximately 12 seconds.RMS measured using high-density EMG electrode grids

Secondary

MeasureTime frameDescription
Spatial Distribution of Muscle ActivationMeasured during 2nd-9th repetitions of the arm elevation task. Each repetition lasted approximately 1.5 seconds, thus the timeframe was approximately 12 seconds.shifts in excitation measured using high-density EMG electrode grids

Countries

Canada

Participant flow

Pre-assignment details

3 participants excluded due to not meeting inclusion criteria.

Participants by arm

ArmCount
No-tape, Experimental KT, Sham KT
Participants were asked to perform a repeated arm elevation task during three different taping conditions: no KT, experimental KT and sham KT. Each taping condition performed the repeated arm elevation task during two loading conditions: no load and loaded with 2.3 kilograms. All six conditions were tested during one visit with the no load condition preceding the loaded condition for each taping condition. This trial consisted of a baseline trial (no KT; N-KT) that was performed first, followed by both an experimental-KT (E-KT) and sham-KT (S-KT) condition. kinesio-tape: Twenty-one individuals with healthy shoulders completed 10 repetitions of an arm elevation task during three taping conditions (no-tape, experimental KT, sham KT) and 2 loading conditions (no-load and loaded).
11
No-tape, Sham KT, Experimental KT
Participants were asked to perform a repeated arm elevation task during three different taping conditions: no KT, experimental KT and sham KT. Each taping condition performed the repeated arm elevation task during two loading conditions: no load and loaded with 2.3 kilograms. All six conditions were tested during one visit with the no load condition preceding the loaded condition for each taping condition. This trial consisted of a baseline trial (no KT; N-KT) that was performed first, followed by both a sham-KT (S-KT) condition and experimental-KT (E-KT). kinesio-tape: Twenty-one individuals with healthy shoulders completed 10 repetitions of an arm elevation task during three taping conditions (no-tape, experimental KT, sham KT) and 2 loading conditions (no-load and loaded).
11
Total22

Baseline characteristics

CharacteristicNo-tape, Experimental KT, Sham KTNo-tape, Sham KT, Experimental KTTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
11 Participants11 Participants22 Participants
Age, Continuous24 Years
STANDARD_DEVIATION 3
24 Years
STANDARD_DEVIATION 3
24 Years
STANDARD_DEVIATION 3
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
11 Participants11 Participants22 Participants
Region of Enrollment
Canada
11 Participants11 Participants22 Participants
Sex: Female, Male
Female
5 Participants6 Participants11 Participants
Sex: Female, Male
Male
6 Participants5 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Whole-muscle Activation

RMS measured using high-density EMG electrode grids

Time frame: Measured during 2nd-9th repetitions of the arm elevation task. Each repetition lasted approximately 1.5 seconds, thus the timeframe was approximately 12 seconds.

ArmMeasureValue (MEAN)Dispersion
No-tape, no LoadWhole-muscle Activation.046 VStandard Deviation 0.019
Sham KT, No-loadWhole-muscle Activation.043 VStandard Deviation 0.015
Kinesio Tape, No-loadWhole-muscle Activation.040 VStandard Deviation 0.018
No-tape, With LoadWhole-muscle Activation.061 VStandard Deviation 0.021
Sham KT, With LoadWhole-muscle Activation.065 VStandard Deviation 0.02
Kinesio Tape, With LoadWhole-muscle Activation.064 VStandard Deviation 0.026
Secondary

Spatial Distribution of Muscle Activation

shifts in excitation measured using high-density EMG electrode grids

Time frame: Measured during 2nd-9th repetitions of the arm elevation task. Each repetition lasted approximately 1.5 seconds, thus the timeframe was approximately 12 seconds.

ArmMeasureValue (MEAN)Dispersion
No-tape, no LoadSpatial Distribution of Muscle Activation.111 mVStandard Deviation 0.05
Sham KT, No-loadSpatial Distribution of Muscle Activation.114 mVStandard Deviation 0.05
Kinesio Tape, No-loadSpatial Distribution of Muscle Activation.111 mVStandard Deviation 0.06
No-tape, With LoadSpatial Distribution of Muscle Activation.105 mVStandard Deviation 0.04
Sham KT, With LoadSpatial Distribution of Muscle Activation.111 mVStandard Deviation 0.04
Kinesio Tape, With LoadSpatial Distribution of Muscle Activation.109 mVStandard Deviation 0.047
Row 3 BaselineSpatial Distribution of Muscle Activation.088 mVStandard Deviation 0.03
Row 3 ShamSpatial Distribution of Muscle Activation.093 mVStandard Deviation 0.03
Row 3 ktSpatial Distribution of Muscle Activation.093 mVStandard Deviation 0.03
Row 4 BaselineSpatial Distribution of Muscle Activation.066 mVStandard Deviation 0.02
Row 4 ShamSpatial Distribution of Muscle Activation.07 mVStandard Deviation 0.02
Row 4 ktSpatial Distribution of Muscle Activation.07 mVStandard Deviation 0.03
Row 5 BaselineSpatial Distribution of Muscle Activation.05 mVStandard Deviation 0.02
Row 5 ShamSpatial Distribution of Muscle Activation.05 mVStandard Deviation 0.02
Row 5 KTSpatial Distribution of Muscle Activation.05 mVStandard Deviation 0.02
Row 6 BaselineSpatial Distribution of Muscle Activation.03 mVStandard Deviation 0.01
Row 6 ShamSpatial Distribution of Muscle Activation.03 mVStandard Deviation 0.01
Row 6 KTSpatial Distribution of Muscle Activation.04 mVStandard Deviation 0.01
Row 7 BaselineSpatial Distribution of Muscle Activation.02 mVStandard Deviation 0.01
Row 7 ShamSpatial Distribution of Muscle Activation.02 mVStandard Deviation 0.01
Row 7 KTSpatial Distribution of Muscle Activation.03 mVStandard Deviation 0.01
Row 8 BaselineSpatial Distribution of Muscle Activation.02 mVStandard Deviation 0.01
Row 8 ShamSpatial Distribution of Muscle Activation.02 mVStandard Deviation 0.01
Row 8 KTSpatial Distribution of Muscle Activation.02 mVStandard Deviation 0.01

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026